Ramasharma K, Li C H
Proc Natl Acad Sci U S A. 1987 Jun;84(11):3595-8. doi: 10.1073/pnas.84.11.3595.
We investigated the binding of 125I-labeled alpha-inhibin-92 (a 92-residue peptide) to human pituitary membrane preparations. Unlabeled alpha-inhibin-92 competed effectively with the labeled peptide for binding to the membranes. Binding was also inhibited by both alpha-inhibin-52 and alpha-inhibin-31, but less effectively. Scatchard analysis of the alpha-inhibin-92 binding data indicated the presence of high-affinity binding sites (1.35 nM/mg of membrane protein) with an apparent Kd of 0.37 nM. When 125I-labeled alpha-inhibin-92 was covalently crosslinked to the pituitary membrane preparation with disuccinimidyl suberate and the solubilized labeled receptor complex was analyzed by NaDodSO4/PAGE under either reducing or nonreducing conditions, a single radioactive band at an apparent molecular weight of 90,000 +/- 5000 was observed. These data suggest that human pituitary has specific binding sites for alpha-inhibins.
我们研究了125I标记的α-抑制素-92(一种含92个氨基酸残基的肽)与人垂体膜制剂的结合情况。未标记的α-抑制素-92能有效地与标记肽竞争结合膜。α-抑制素-52和α-抑制素-31也能抑制结合,但效果较差。对α-抑制素-92结合数据的Scatchard分析表明存在高亲和力结合位点(1.35 nM/mg膜蛋白),表观解离常数(Kd)为0.37 nM。当用辛二酸二琥珀酰亚胺酯将125I标记的α-抑制素-92与垂体膜制剂共价交联,并用十二烷基硫酸钠/聚丙烯酰胺凝胶电泳(NaDodSO4/PAGE)在还原或非还原条件下分析溶解的标记受体复合物时,观察到一条表观分子量为90,000±5000的单一放射性条带。这些数据表明人垂体存在α-抑制素的特异性结合位点。